The Global Needle-Free Delivery Technology market will reach $2,093.9m in 2020 predicts new visiongain report

03 September 2018
Pharma

A new report by visiongain predicts that the Global Needle-Free Delivery Technology market will reach $2,093.9m in 2020. This forecast and others appear in Needle-Free Delivery Technology Market Forecast 2016-2026: Analysis and Forecasts for Jet Injector Technologies and Competing Technologies including Novel Needle Technology, Inhaler Technology and Microneedle Technology with an Assessment of Leading Companies including Antares, Zogenix and 3M—published in August 2016. Visiongain is a business information provider based in London, UK.

Needle-Free Delivery Technology Market Forecast 2016-2026: Analysis and Forecasts for Jet Injector Technologies and Competing Technologies including Novel Needle Technology, Inhaler Technology and Microneedle Technology with an Assessment of Leading Companies including Antares, Zogenix and 3M report examines the current and future trends in the growing needle-free delivery technology market. Needle-free delivery technologies will become more widely used in the next ten years. The need for improved needle-free delivery technologies and demand for less invasive drug administration procedures will be a major driver for the needle-free delivery technologies market. In addition, the growing diabetic patient population and need for improved patient compliance for children/elderly in most developed markets will help to drive the demand for needle-free delivery technologies.
In this report, we examine in detail the needle-free delivery technology market, and provide analyses and forecasts for regional and national markets. Historical revenues have also been added to strengthen our analysis to demonstrate how this market has changed. Qualitative analysis of the market is given, taking into account governmental policy and regulation, safety, features and more.

Visiongain’s report provides revenue forecasts to 2026 for the global medical laser systems market and the leading regional and national medical laser markets. The report discusses selected leading companies in the market. These companies include Antares Pharma, Beckton Dickinson and Company (BD), Bioject Medical Technologies, PharmaJet, Zogenix and 3M.

Needle-Free Delivery Technology Market Forecast 2016-2026: Analysis and Forecasts for Jet Injector Technologies and Competing Technologies including Novel Needle Technology, Inhaler Technology and Microneedle Technology with an Assessment of Leading Companies including Antares, Zogenix and 3M adds to visiongain’s range of analytical reports on industries and markets in healthcare.

For an executive summary please contact:
Email: Sara Peerun on sara.peerun@visiongainglobal.com
Tel: +44 (0) 20 7336 6100

Notes for Editors

If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 61
About visiongain

Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. From its head office in London, UK, visiongain produces a range of newsletters, business reports and e-zines covering current affairs and market trends in the Energy, Telecoms, Pharmaceutical, Defence, and Materials sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional that needs independent, high quality, original analyses to inform their strategic decisions.

Recent News

Visiongain Publishes Protein Labelling Reagents for Research Use Only (RUO) Market Report 2021-2031

Increasing investment in R&D for proteomics research, by both public and private organizations, is one of the major contributors to the growth of the protein labelling reagents market. The increasing prevalence of chronic diseases is also expected to contribute to the growth of this market.

05 May 2021

Read

Visiongain Publishes Aptamer Technologies Market Report 2021-2031

Over the last few years, the aptamers has gained widespread attention due to the technological advancements and growth in understanding of the oligonucleotide therapeutics that inhabit the human body.

29 April 2021

Read

Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031

Rising prevalence of inflammatory bowel disease including Crohn’s disease and ulcerative colitis; raising awareness for IBD in developing countries; escalating investment in drug R&D by pharmaceutical companies; new product launches worldwide, growing chronic diseases healthcare awareness are some of the major factors that boosting the growth of global IBD drugs market.

29 April 2021

Read

Visiongain Publishes Antiviral Drugs Treatment Market Report 2021-2031

Rising incidences of viral infection; increasing geriatric population is projected to propel the demand for anti-viral drugs; advancement in anti-viral drugs R&D is driving the market growth; and rising strategic initiatives for anti-viral drugs market is another major factor propelling the market growth worldwide are some of the major factors that propel the global antiviral drugs treatment market growth.

28 April 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever